Similar Articles
531 Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
532 Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect
533 Current status of radical laparoscopy for treating hepatocellular carcinoma with portal hypertension
534 Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
535 Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization
536 Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report
537 Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
538 Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
539 Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression
540 Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidance
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA